Is ZTS Worth Buying in 2026?

ZOETIS INC.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-16

Here’s whether ZOETIS INC. (ZTS) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Positives: RSI 43 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-0.97% over 10 days); weak 1-year return of -51.8%; rising volume on a downtrend (distribution, 1.31x avg). Currently 54.0% off its 52-week high. Score: -4/7.

Ready to act on this? 📈 Trade on Webull

ZTS is trading below its 200-day MA ($106.96) — a key warning sign the longer-term trend is under pressure. An RSI of 43.3 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -51.8% compares to +20.4% for SPY (trailed the market by 72.2%). The current 54.0% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $4,821 today
vs. S&P 500 (SPY) — same period trailed market by 72.2%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($106.96)
Above 50-day MA ($76.43)
RSI(14) neutral zone (30–70) — currently 43.3
Positive return (-51.8%)
!Within 10% of period high (−54.0%)
Period Range $73.79
$71.45 $160.48
RSI (14) 43.3
0 · OversoldOverbought · 100

Key Metrics

Price$73.79
Period Return-51.8%
Period High$160.48
Period Low$71.45
Drawdown−54.0%
MA-50$76.43
MA-200$106.96
RSI (14)43.3
Avg Volume (30d)6.6M
vs. SPYtrailed by 72.2%
Return Rank#1078 of 1252

Trade ZTS

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers